您的当前位置:首页 > 行业数据 > 图14.泽布替尼在美国新增CLL患者中处方量排名第一
图片属性
图片格式:PNG 图片大小:200KB 图片尺寸:2332*847
同报告图片
 / 4
图14.泽布替尼在美国新增CLL患者中处方量排名第一_第1页
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
图14.泽布替尼在美国新增CLL患者中处方量排名第一_第2页
55Sx5LqO5oKo5o+Q5L6b55qE5Zu+54mH5YaF5a656L6D5Li65qih57OK77yM5peg5rOV6K+G5Yir5YW35L2T55qE5paH5a2X5YaF5a6577yM5Zug5q2k5oiR5peg5rOV5Li65oKo5o+Q5L6b5YeG56Gu55qE6KGo5qC844CC5aaC5p6c5oKo6IO95o+Q5L6b5pu05riF5pmw55qE5Zu+54mH5oiW6ICF5paH5a2X5YaF5a6577yM5oiR5Lya5b6I5LmQ5oSP5biu5Yqp5oKo5o+Q5Y+W5pWw5o2u5bm255Sf5oiQ6KGo5qC844CC
图14.泽布替尼在美国新增CLL患者中处方量排名第一_第3页
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
图14.泽布替尼在美国新增CLL患者中处方量排名第一_第4页
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
图14.泽布替尼在美国新增CLL患者中处方量排名第一_第5页
fCDnmb7mtY7npZ7lt57ogqHmnYPnu5PmnoTvvIjmiKroh7MyMDI05bm0NuaciO+8iSB8IOWuiei/myB8IOmrmOeTtEhITFIgRnVuZCB8IEJha2VyIEJyb3RoZXJzIExpZmUgU2NpZW5jZXMgfCBDYXBpdGFsIFJlc2VhcmNoIGFuZCBNYW5hZ2VtZW50IENvbXBhbnkgfCDlhbbku5bogqHkuJwgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6IKh5p2D5q+U5L6LIHwgMTcuODYlIHwgMTAuMzYlIHwgMTAuMDYlIHwgNy45OCUgfCAtIHwKCui1hOaWmeadpea6kO+8mueZvua1juelnuW3nuW5tOaKpe+8jEhUSQ==
所属报告: 百济神州-港股公司首次覆盖报告:从实验室迈向全球化中国Biopharma龙头正在破茧成蝶-250305(35页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠